Protein–excipient interactions: Mechanisms and biophysical characterization applied to protein formulation development
TJ Kamerzell, R Esfandiary, SB Joshi… - Advanced drug delivery …, 2011 - Elsevier
The purpose of this review is to demonstrate the critical importance of understanding protein–
excipient interactions as a key step in the rational design of formulations to stabilize and …
excipient interactions as a key step in the rational design of formulations to stabilize and …
Differential scanning calorimetry as a tool for protein folding and stability
CM Johnson - Archives of biochemistry and biophysics, 2013 - Elsevier
Differential scanning calorimetry measures the heat capacity of states and the excess heat
associated with transitions that can be induced by temperature change. The integral of the …
associated with transitions that can be induced by temperature change. The integral of the …
Developability assessment during the selection of novel therapeutic antibodies
A Jarasch, H Koll, JT Regula, M Bader… - Journal of …, 2015 - Elsevier
Therapeutic antibodies and antibody derivatives comprise the majority of today's
biotherapeutics. Routine methods to generate novel antibodies, such as immunization and …
biotherapeutics. Routine methods to generate novel antibodies, such as immunization and …
The impact of glycosylation on monoclonal antibody conformation and stability
K Zheng, C Bantog, R Bayer - MAbs, 2011 - Taylor & Francis
Antibody glycosylation is a common post-translational modification and has a critical role in
antibody effector function. The use of glycoengineering to produce antibodies with specific …
antibody effector function. The use of glycoengineering to produce antibodies with specific …
Forced degradation of therapeutic proteins
A Hawe, M Wiggenhorn, M van de Weert… - Journal of …, 2012 - Elsevier
The scope of this paper is to review approaches used for forced degradation (synonym,
stress testing) of therapeutic proteins. Forced degradation studies play a central role in the …
stress testing) of therapeutic proteins. Forced degradation studies play a central role in the …
Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool
Y Xu, W Roach, T Sun, T Jain, B Prinz… - … , Design & Selection, 2013 - academic.oup.com
Low expression, poor solubility, and polyspecificity are significant obstacles that have
impeded the development of antibodies discovered from in vitro display libraries. Current …
impeded the development of antibodies discovered from in vitro display libraries. Current …
A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties
T Tiller, I Schuster, D Deppe, K Siegers, R Strohner… - MAbs, 2013 - Taylor & Francis
This report describes the design, generation and testing of Ylanthia, a fully synthetic human
Fab antibody library with 1.3 E+ 11 clones. Ylanthia comprises 36 fixed immunoglobulin (Ig) …
Fab antibody library with 1.3 E+ 11 clones. Ylanthia comprises 36 fixed immunoglobulin (Ig) …
Auristatin antibody drug conjugate physical instability and the role of drug payload
YT Adem, KA Schwarz, E Duenas… - Bioconjugate …, 2014 - ACS Publications
The conjugation of hydrophobic cytotoxic agents such as monomethyl auristatin E (MMAE)
to the interchain sulfhydryl groups of monoclonal antibodies (Mabs) through a protease …
to the interchain sulfhydryl groups of monoclonal antibodies (Mabs) through a protease …
Structure, heterogeneity and developability assessment of therapeutic antibodies
Y Xu, D Wang, B Mason, T Rossomando, N Li, D Liu… - MAbs, 2019 - Taylor & Francis
Increasing attention has been paid to developability assessment with the understanding that
thorough evaluation of monoclonal antibody lead candidates at an early stage can avoid …
thorough evaluation of monoclonal antibody lead candidates at an early stage can avoid …
Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics
W Zhang, H Wang, N Feng, Y Li, J Gu… - Antibody …, 2023 - academic.oup.com
Developability refers to the likelihood that an antibody candidate will become a
manufacturable, safe and efficacious drug. Although the safety and efficacy of a drug …
manufacturable, safe and efficacious drug. Although the safety and efficacy of a drug …